Stefano Bradamante

  • Research engineer; BSc
  • +47 22 78 23 18

Research & Development

Education:

 2000-2009 – BSc in Physics - Università degli studi di Trieste 

 

Work experience:

Sept. 2021 – Present – Research Engineer, Dept. of Cellular Therapy, OUS-Radiumhospitalet, Oslo, Norway

Jan. 2018 – Dec.2020 – Research Engineer, Department of Cancer Research and Molecular Medicine, NTNU, Trondheim, Norway

Oct. 2017 – Dec.2017 – Animal Technician, Comparative medicine core facility, NTNU, Trondheim, Norway

Sept. 2016 – July 2017 – Research Engineer, Department of Cancer Research and Molecular Medicine, NTNU, Trondheim, Norway

April 2014 – June 2016 – Research Engineer and Animal Technician, Kavli Institute for Systems Neuroscience, NTNU, Trondheim, Norway

March 2013 – May 2013 – Trainee, Kavli Institute for Systems Neuroscience, NTNU, Trondheim, Norway

 

Research interests/projects:

Publications:

Increased p53 signaling impairs neural differentiation causing HUWE1-promoted intellectual disabilities.

Aprigliano R, Bradamante S, Mihaljevic B, Wang W, Martin SL, Bordin DL, Bosshard M, Montaldo NP, Peng Y, Alexov E, Skinner C. (et al.) 

Cell Reports Medicine. 2021 Mar 16

 

Alkyladenine DNA glycosylase associates with transcription elongation to coordinate DNA repair with gene expression.

Montaldo NP, Bordin DL, Brambilla A, Rösinger M, Martin SL, Bjørås KØ, Bradamante S, Aas PA, Furrer A, Olsen LC, Kunath N. (et al.)

Nature communications. 2019 Nov 29;10(1):1-3.

 

Normal development of mice lacking PAXX, the paralogue of XRCC 4 and XLF

Gago‐Fuentes R, Xing M, Sæterstad S, Sarno A, Dewan A, Beck C, Bradamante S, Bjørås M, Oksenych V.

FEBS open bio. 2018 Mar;8(3):426-34.

 

 
Page visits: 74